Real Estate - Services
Compare Stocks
2 / 10Stock Comparison
EXPI vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
EXPI vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Real Estate - Services | REIT - Healthcare Facilities |
| Market Cap | $1.01B | $150.14B |
| Revenue (TTM) | $4.77B | $11.63B |
| Net Income (TTM) | $-23M | $1.43B |
| Gross Margin | 7.0% | 39.1% |
| Operating Margin | -0.4% | 4.4% |
| Forward P/E | 89.7x | 78.9x |
| Total Debt | $0.00 | $21.38B |
| Cash & Equiv. | $124M | $5.03B |
EXPI vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| eXp World Holdings,… (EXPI) | 100 | 117.4 | +17.4% |
| Welltower Inc. (WELL) | 100 | 422.9 | +322.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EXPI vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EXPI is the clearest fit if your priority is long-term compounding.
- 6.6% 10Y total return vs WELL's 230.2%
- 3.1% yield, vs WELL's 1.3%
WELL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs EXPI's 4.5% | |
| Value | Lower P/E (78.9x vs 89.7x) | |
| Quality / Margins | 12.3% margin vs EXPI's -0.5% | |
| Stability / Safety | Beta 0.13 vs EXPI's 1.57 | |
| Dividends | 3.1% yield, vs WELL's 1.3% | |
| Momentum (1Y) | +43.9% vs EXPI's -25.7% | |
| Efficiency (ROA) | 2.3% ROA vs EXPI's -5.1%, ROIC 0.5% vs -15.3% |
EXPI vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EXPI vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
WELL leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 2.4x EXPI's $4.8B. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to EXPI's -0.5%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4.8B | $11.6B |
| EBITDAEarnings before interest/tax | -$12M | $2.8B |
| Net IncomeAfter-tax profit | -$23M | $1.4B |
| Free Cash FlowCash after capex | $108M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +7.0% | +39.1% |
| Operating MarginEBIT ÷ Revenue | -0.4% | +4.4% |
| Net MarginNet income ÷ Revenue | -0.5% | +12.3% |
| FCF MarginFCF ÷ Revenue | +2.3% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.5% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -24.4% | +22.5% |
Valuation Metrics
EXPI leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.0B | $150.1B |
| Enterprise ValueMkt cap + debt − cash | $887M | $166.5B |
| Trailing P/EPrice ÷ TTM EPS | -44.86x | 154.17x |
| Forward P/EPrice ÷ next-FY EPS est. | 89.71x | 78.89x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 66.76x |
| Price / SalesMarket cap ÷ Revenue | 0.21x | 14.08x |
| Price / BookPrice ÷ Book value/share | 4.13x | 3.37x |
| Price / FCFMarket cap ÷ FCF | 9.28x | 52.72x |
Profitability & Efficiency
WELL leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-9 for EXPI. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs EXPI's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -9.4% | +3.5% |
| ROA (TTM)Return on assets | -5.1% | +2.3% |
| ROICReturn on invested capital | -15.3% | +0.5% |
| ROCEReturn on capital employed | -9.6% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | — | 0.49x |
| Net DebtTotal debt minus cash | -$124M | $16.3B |
| Cash & Equiv.Liquid assets | $124M | $5.0B |
| Total DebtShort + long-term debt | $0 | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,264 today (with dividends reinvested), compared to $2,329 for EXPI. Over the past 12 months, WELL leads with a +43.9% total return vs EXPI's -25.7%. The 3-year compound annual growth rate (CAGR) favors WELL at 41.3% vs EXPI's -19.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -30.4% | +15.0% |
| 1-Year ReturnPast 12 months | -25.7% | +43.9% |
| 3-Year ReturnCumulative with dividends | -47.9% | +182.2% |
| 5-Year ReturnCumulative with dividends | -76.7% | +212.6% |
| 10-Year ReturnCumulative with dividends | +662.8% | +230.2% |
| CAGR (3Y)Annualised 3-year return | -19.5% | +41.3% |
Risk & Volatility
WELL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than EXPI's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 97.6% from its 52-week high vs EXPI's 51.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.57x | 0.13x |
| 52-Week HighHighest price in past year | $12.23 | $219.59 |
| 52-Week LowLowest price in past year | $5.66 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +51.3% | +97.6% |
| RSI (14)Momentum oscillator 0–100 | 47.1 | 62.6 |
| Avg Volume (50D)Average daily shares traded | 1.0M | 2.6M |
Analyst Outlook
Evenly matched — EXPI and WELL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates EXPI as "Buy" and WELL as "Buy". Consensus price targets imply 75.2% upside for EXPI (target: $11) vs 5.7% for WELL (target: $227). For income investors, EXPI offers the higher dividend yield at 3.07% vs WELL's 1.29%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $11.00 | $226.50 |
| # AnalystsCovering analysts | 5 | 34 |
| Dividend YieldAnnual dividend ÷ price | +3.1% | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $0.19 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.6% | 0.0% |
WELL leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EXPI leads in 1 (Valuation Metrics). 1 tied.
EXPI vs WELL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is EXPI or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 4. 5% for eXp World Holdings, Inc. (EXPI). Welltower Inc. (WELL) offers the better valuation at 154. 2x trailing P/E (78. 9x forward), making it the more compelling value choice. Analysts rate eXp World Holdings, Inc. (EXPI) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EXPI or WELL?
On forward P/E, Welltower Inc.
is actually cheaper at 78. 9x.
03Which is the better long-term investment — EXPI or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +212. 6%, compared to -76. 7% for eXp World Holdings, Inc. (EXPI). Over 10 years, the gap is even starker: EXPI returned +662. 8% versus WELL's +230. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EXPI or WELL?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus eXp World Holdings, Inc. 's 1. 57β — meaning EXPI is approximately 1082% more volatile than WELL relative to the S&P 500.
05Which is growing faster — EXPI or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 4. 5% for eXp World Holdings, Inc. (EXPI). On earnings-per-share growth, the picture is similar: eXp World Holdings, Inc. grew EPS 0. 0% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EXPI or WELL?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -0. 5% for eXp World Holdings, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 3. 3% versus -0. 4% for EXPI. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EXPI or WELL more undervalued right now?
On forward earnings alone, Welltower Inc.
(WELL) trades at 78. 9x forward P/E versus 89. 7x for eXp World Holdings, Inc. — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EXPI: 75. 2% to $11. 00.
08Which pays a better dividend — EXPI or WELL?
All stocks in this comparison pay dividends.
eXp World Holdings, Inc. (EXPI) offers the highest yield at 3. 1%, versus 1. 3% for Welltower Inc. (WELL).
09Is EXPI or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +230. 2% 10Y return). eXp World Holdings, Inc. (EXPI) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (WELL: +230. 2%, EXPI: +662. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EXPI and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EXPI is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.